-
FDA warnings
Dec 02, 10 FDA warningsThe U.S. Food and Drug Administration declined to approve an experimental epilepsy drug from GlaxoSmithKline and Valeant Pharmaceuticals International, the… »
Dec 01, 10 FDA warningsAn experimental AstraZeneca pill to treat inoperable thyroid cancer carries “substantial toxicity” for patients, U.S. drug reviewers said in documents… »
Nov 25, 10 FDA warningsJohnson & Johnson said on Wednesday that it was recalling 9 million more bottles of its Tylenol painkiller because they… »
Nov 24, 10 FDA warningsJohnson & Johnson, which has been beset with recalls of Tylenol and other consumer products over the past year, has… »
Nov 05, 10 FDA warningsUsing high doses of Novo Nordisk’s anti-clotting medicine to treat dangerous bleeding in non-hemophiliacs may raise the risk of heart… »
Oct 28, 10 FDA warningsHope for a new prescription weight-loss pill bit the dust over the weekend when the FDA rejected lorcaserin, calling any… »
Oct 18, 10 FDA warningsRoche Holding AG and Biogen Idec Inc reported data from a mid-stage trial of their experimental multiple sclerosis drug ocrelizumab… »
Oct 16, 10 FDA warningsThe U.S. Food and Drug Administration is cracking down on the over-the-counter sale of so-called chelation products that claim to… »
Sep 30, 10 FDA warningsBristol-Myers Squibb Co is recalling 60 million tablets of the blood pressure medication Avalide in the United States and Puerto… »
Sep 24, 10 FDA warningsEuropean regulators said on Thursday GlaxoSmithKline’s diabetes drug Avandia should be taken off the market but U.S. officials allowed it… »
Sep 17, 10 FDA warningsU.S. advisers rejected Arena Pharmaceuticals Inc’s experimental weight-loss pill on Thursday, a major setback for the company that is trying… »
Sep 17, 10 FDA warningsA U.S. advisory panel was divided over whether to recommend banning Abbott Laboratories’ controversial weight-loss drug on Wednesday, although most… »
Sep 14, 10 FDA warningsU.S. health regulators could pull the controversial weight-loss drug Meridia (from Abbott Laboratories) off the market over heart problems, according… »
Jul 22, 10 FDA warningsA U.S. panel urged officials to revoke the drug Avastin’s approval for breast cancer after concluding studies showed insufficient… »
Jul 06, 10 FDA warningsNovartis AG’s cancer drug Afinitor has been rejected for patients with kidney cancer by Britain’s health costs watchdog, which… »
Subscribe to the "News" RSS Feed 
TOP ۞
